BioSpace News Archive

Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the commercial launch of its new NKV-550 Series Ventilator System, which offers a full suite of applications necessary in a critical care setting for patients of all ages – from neonate through adult.

Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat Alzheimer’s and other degenerative diseases, today announced the publication of new data in Pharmacology Research and Perspectives revealing further detail about the pharmacodynamics and utility of the company’s lead investigational medicine, COR388.

Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce that its wholly-owned subsidiary, Natural MedCo Ltd. (“Natural MedCo”), has entered into an exclusive letter of intent (the “LOI”) with ECS BioMed Inc. (“Dr. Kerklaan Therapeutics”) effective January 14, 2020.

RightEye LLC, an award-winning health technology company using eye tracking to help diagnose health and vision issues as well as improve performance vision, today announced the publication of a study, co-authored by RightEye co-founder and Chief Science Officer Dr. Melissa Hunfalvay,

Greenphire, the global leader in financial software for clinical trials, today announced that its CEO, Jim Murphy, will co-present alongside Lazarex Cancer Foundation Founder, Dana Dornsife, at the Society for Clinical Research Sites (SCRS)'s annual Global Oncology Site Solutions Summit.

VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) diseases and disorders with high unmet medical need, today announced that its Investigational New Drug (IND) application for AV-101, the Company’s oral NMDAR (N-methyl-D-aspartate receptor) glycine site antagonist

Dr. Gregg Soifer, MD with Clinic4Men.com is making waves in the medical world of sexual wellness by joining the GAINSWave® movement to offer GAINSWave treatment!

Healthfirst announced today that it is teaming with NationsHearing to provide an enhanced hearing health solution for its Medicare Advantage plan members, including Healthfirst CompleteCare (HMO SNP) plan members.

Ziopharm Oncology, Inc. (Nasdaq:ZIOP), today announced two publications in peer-reviewed scientific journals supporting the Company’s ongoing clinical programs by reinforcing two of the foundational technologies underlying the Company’s approach to the genetic modification of T cells to target cancer

Neogen Corporation (NASDAQ: NEOG) announced today that it and Angus Genetics, Inc. (AGI) have launched updated content to Angus GSSM — the first genomic profiler designed specifically for Angus cattle.